Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Collard, Jean Marc ^a,g,h   Issaka, Bassira ^a   Zaneidou, Maman ^b   Hugonnet, Stéphane ^c   Nicolas, Pierre ^d   Taha, Muhamed Kheir ^e   Greenwood, Brian ^f   Jusot, Jean François ^a  

^a Centre de Recherche Medicale et Sanitaire   (Niger)

^b Ministry of Health Niamey   (Niger)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d SERVICE DE SANTÉ DES ARMÉES   (France)

^e INSTITUT PASTEUR   (France)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g Scientific Institute of Public Health ^*  (Niger)

^h SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

Immunization; MenAfriVac ; Meningitis; Neisseria meningitidis serogroup A and W; Niger; Sequence type lineage evolution; Vaccination

Indexed keywords

MENINGOCOCCUS VACCINE;

AGE DISTRIBUTION; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CEREBROSPINAL FLUID ANALYSIS; DRUG EFFICACY; DRUG RESPONSE; EPIDEMIC MENINGITIS; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MASS IMMUNIZATION; MOLECULAR TYPING; NEISSERIA MENINGITIDIS; NIGER; NONHUMAN; PREVALENCE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; HUMANS; MASS VACCINATION; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NIGER; POPULATION SURVEILLANCE; SEROTYPING; VACCINES, CONJUGATE; YOUNG ADULT;

EID: 84889032744     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-576     Document Type: Article

References (29)

1. Sultan B, Labadi K, Guégan JF, Janicot S. Climates drives the meningitis epidemics onset in West Africa. PLoS Med 2005, 2(1):43-49.
2. Whittle HC, Greenwood BM. Meningococcal meningitis in northern savanna of Africa. Trop Doct 1976, 6:99-104.
3. Broome CV, Rugh MA, Yada AA, Giat L, Giat H, Zeltner JM, Sanborn WR, Fraser DW. Epidemic group C meningococcal meningitis in Upper Volta, 1979. Bull World Health Organ 1983, 61(2):325-330. 2536118, 6345014.
4. Decosas J, Koama JB. Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso. Lancet Infect Dis 2002, 2(12):763-765. 10.1016/S1473-3099(02)00455-3, 12467693.
5. Zombre S, Hacen MM, Ouango G, Sanou S, Adamou Y, Koumaré B, Kondé MK. The outbreak of meningitis due to Neisseria meningitidis W135 in 2003 in Burkina Faso and the national response: main lessons learnt. Vaccine 2007, 25(Suppl 1):A69-A71.
6. Boisier P, Nicolas P, Djibo S, Taha MK, Jeanne I, Maïnassara HB, Tenebray B, Kairo KK, Giorgini D, Chanteau S. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clin Infect Dis 2007, 44(5):657-663. 10.1086/511646, 17278055.
7. World Health Organization Detecting meningococcal meningitis epidemics in highly-endemic African countries. Wkly Epidemiol Rec 2000, 75(38):305-312. World Health Organization.
8. LaForce MF, Ravenscroft N, Djingarey M, Viviani S. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: A persistent problem with an imminent solution. Vaccine 2009, 27(Suppl 2):B13-B19.
9. Kristiansen PA, Diomandé F, Ba AK, Sanou I, Ouédraogo AS, Ouédraogo R, Sangaré L, Kandolo D, Aké F, Saga IM, Clark TA, Misegades L, Martin SW, Thomas JD, Tiendrebeogo SR, Hassan-King M, Djingarey MH, Messonnier NE, Préziosi MP, Laforce FM, Caugant DA. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis 2013, 56(3):354-363. 10.1093/cid/cis892, 23087396.
10. Daugla D, Gami J, Gamougam K, Naibei N, Mbainadji L, Narbé M, Toralta J, Kodbesse B, Ngadoua C, Coldiron M, Fermon F, Page AL, Djingarey M, Hugonnet S, Harrison O, Rebbetts L, Tekletsion Y, Watkins E, Hill D, Caugant D, Chandramohan D, Hassan-King M, Manigart O, Nascimento M, Woukeu A, Trotter C, Stuart J, Maiden M, Greenwood B. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community trial. Lancet 2013, 6736(13):61612-61618.
11. Campbell H, Borrow R, Salisbury D, Miller E. Meningococcal C conjugate vaccine: the experience in England and Wales. Vaccine 2009, 27(Suppl 2):B20-B29.
12. Chanteau S, Sidikou F, Djibo S, Moussa A, Mindadou H, Boisier P. Scaling up of PCR-based surveillance of bacterial meningitis in the African meningitis belt: indisputable benefits of multiplex PCR assay in Niger. Trans R Soc Trop Med Hyg 2006, 100(7):677-680. 10.1016/j.trstmh.2005.09.006, 16359713.
13. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, Zhang Q, Zhou J, Zurth K, Caugant DA, Feavers IM, Achtman M, Spratt BG. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 1998, 95(6):3140-3145. 10.1073/pnas.95.6.3140, 19708, 9501229.
14. Djibo S, Nicolas P, Alonso JM, Djibo A, Couret D, Riou JY, Chippaux JP. Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000. Trop Med Int Health 2003, 8(12):1118-1123. 10.1046/j.1360-2276.2003.01126.x, 14641847.
15. World Health Organization Inter country Support Team - West Africa Weekly feedback bulletin on cerebrospinal meningitis. Epidemiological situation of week 35 -39; From 29 August to 1st October 2011. [http://www.who.int/csr/disease/meningococcal/BulletinMeningite2011_S35_39.pdf], World Health Organization.
16. Lapeyssonnie L. La méningite cérébro-spinale en Afrique. Bull World Health Organ 1963, 28(Suppl):1-114.
17. Nicolas P, Décousset L, Riglet V, Castelli P, Stor R, Blanchet G. Multilocus sequence typing of serogroup A meningococci isolated in Africa between 1988 and 1999 shows the clonal expansion of ST-5 and emergence of ST-7. Emerg Infect Dis 2001, 7(5):849-854. 2631866, 11747698.
18. Nicolas P, Djibo S, Moussa A, Tenebray B, Boisier P, Chanteau S. Molecular epidemiology of meningococci isolated in Niger in 2003 shows serogroup A sequence type (ST)-7 and serogroup W135 ST-11 and T-2881 strains. J Clin Microbiol 2005, 43(3):1437-1438. 10.1128/JCM.43.3.1437-1438.2005, 1081239, 15750126.
19. Collard JM, Maman Z, Abani A, Mainasara HB, Djibo S, Yacouba H, Maitournam R, Sidikou F, Nicolas P, Rocourt J, Jusot JF. Microbiological and epidemiological investigation of the Neisseria meningitidis serogroup A epidemic in Niger in 2009: last wave before the introduction of the serogroup A meningococcal conjugate vaccine?. Epidemiol Infect 2011, 139(11):1656-1660. 10.1017/S0950268810003092, 21251346.
20. Caugant DA, Kristiansen PA, Wang X, Mayer LW, Taha MK, Ouédraogo R, Kandolo D, Bougoudogo F, Sow S, Bonte L. Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine. PLoS One 2012, 7(9):e46019. 10.1371/journal.pone.0046019, 3459830, 23029368.
21. Huber CA, Pflüger V, Hamid AW, Forgor AA, Hodgson A, Sié A, Junghanss T, Pluschke G. Lack of antigenic diversification of major outer membrane proteins during clonal waves of Neisseria meningitidis serogroup A colonization and disease. FEMS Immunol Med Microbiol 2012, doi:10.1111/1574-695X.12000.
22. Bart A, Barnabé C, Achtman M, Dankert J, van der Ende A, Tibayrenc M. The population structure of Neisseria meningitidis serogroup A fits the predictions for clonality. Infect Genet Evol 2001, 1(2):117-122. 10.1016/S1567-1348(01)00011-9, 12798026.
23. Nicolas P, Norheim G, Garnotel E, Djibo S, Caugant DA. Molecular epidemiology of Neisseria meningitidis isolated in the African meningitis belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. J Clin Microbiol 2005, 43(10):5129-5135. 10.1128/JCM.43.10.5129-5135.2005, 1248450, 16207974.
24. Dellicour S, Greenwood B. Impact of meningococcal vaccination on pharyngeal carriage of meningococci. Trop Med Int Health 2007, 12(12):1409-1421. 10.1111/j.1365-3156.2007.01929.x, 17961128.
25. Hassan-King MKA, Wall RA, Greenwood BM. Meningococcal carriage, meningococcal disease and vaccination. J Infect 1988, 16(1):55-59. 10.1016/S0163-4453(88)96117-8, 3130424.
26. Kwara A, Adegbola RA, Corrah PT, Weber M, Achtman M, Morelli G, Caugant DA, Greewood BM. Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in west Africa. Trop Med Int Health 1998, 3:742-746. 10.1046/j.1365-3156.1998.00300.x, 9754670.
27. Nathan N, Rose AM, Legros D, Tiendrebeogo SR, Bachy C, Bjørløw E, Firmenich P, Guerin PJ, Caugant DA. Meningitis serogroup W135 outbreak, Burkina Faso, 2002. Emerg Infect Dis 2007, 13(6):920-923. 10.3201/eid1306.060940, 2792856, 17553237.
28. Collard JM, Maman Z, Yacouba H, Djibo S, Nicolas P, Jusot JF, Rocourt J, Maitournam R. Increase in Neisseria meningitidis serogroup W135, Niger, 2010. Emerg Infect Dis 2010, 16(9):1496-1498. 10.3201/eid1609.100510, 3294991, 20735947.
29. Paireau J, Girond F, Collard JM, Maïnassara HB, Jusot JF. Analysing spatio-temporal clustering of meningococcal meningitis outbreaks in Niger reveals opportunities for improved disease control. PLoS Negl Trop Dis 2012, 6(3):e1577. 10.1371/journal.pntd.0001577, 3308932, 22448297.